Literature DB >> 33517259

Small-diameter TIPS combined with splenic artery embolization in the management of refractory ascites in cirrhotic patients.

Nathan E Frenk1, Teodora Bochnakova2, Suvranu Ganguli3, Nathaniel Mercaldo4, Andrew S Allegretti5, Daniel S Pratt6, Kei Yamada7.   

Abstract

PURPOSE: Maximally decreasing portal pressures with transjugular intrahepatic portosystemic shunt (TIPS) is associated with improved ascites control but also increased encephalopathy incidence. Since splenic venous flow contributes to portal hypertension, we assessed if combining small-diameter TIPS with splenic artery embolization could improve ascites while minimizing encephalopathy.
METHODS: Fifty-five patients underwent TIPS creation for refractory ascites. Subjects underwent creation of 8 mm TIPS followed by proximal splenic artery embolization (group A, n=8), or of 8 mm (group B, n=6) or 10 mm TIPS (group C, n=41) without splenic embolization. Data were retrospectively reviewed.
RESULTS: In group A, median portosystemic gradient decreased from 19 mmHg to 9 mmHg after TIPS, and 8 mmHg after subsequent splenic artery embolization. In groups B and C, gradient decreased from 15 mmHg to 8 mmHg and 16 mmHg to 6 mmHg. All patients except for one in group A and two in C had greater than 50% reduction in the number of paracenteses in 3 months. Any postprocedural encephalopathy incidence was 62%, 50%, 83% in groups A, B, and C, respectively. Overall, 20% of subjects with 10 mm TIPS required TIPS reduction/closure compared to 7% of subjects with 8 mm TIPS.
CONCLUSION: We found that 8 mm diameter TIPS provided similar ascites control compared to 10 mm TIPS regardless of splenic embolization. While more patients with 10 mm TIPS required reduction/closure for severe encephalopathy, the study was underpowered for definitive assessment. Splenic embolization might have the potential to further decrease portosystemic gradient and ascites as an alternative to dilation of TIPS to 10 mm minimizing the risk of encephalopathy, but larger studies are warranted.

Entities:  

Year:  2021        PMID: 33517259      PMCID: PMC7963388          DOI: 10.5152/dir.2021.19530

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN: 1305-3825            Impact factor:   2.630


  32 in total

1.  Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study.

Authors:  Christophe Bureau; Juan Carlos Garcia-Pagan; Philippe Otal; Gilles Pomier-Layrargues; Valérie Chabbert; Carlos Cortez; Pierre Perreault; Jean Marie Péron; Juan G Abraldes; Louis Bouchard; José Ignacio Bilbao; Jaume Bosch; Hervé Rousseau; Jean Pierre Vinel
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

Review 2.  An Overview of Splenic Embolization.

Authors:  Chaitanya Ahuja; Khashayar Farsad; Meghna Chadha
Journal:  AJR Am J Roentgenol       Date:  2015-10       Impact factor: 3.959

3.  Hemodynamic changes in the hepatic circulation after the modulation of the splenic circulation in an in vivo human experimental model.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Shouichi Satou; Tetsuya Mitsui; Riki Ninomiya; Masahiko Komagome; Fumiaki Ozawa; Yoshifumi Beck
Journal:  Liver Transpl       Date:  2013-11-21       Impact factor: 5.799

4.  Comparison of TIPS alone and combined with partial splenic embolization (PSE) for the management of variceal bleeding.

Authors:  Yue-Meng Wan; Yu-Hua Li; Zhi-Yuan Xu; Hua-Mei Wu; Xi-Nan Wu; Ying Xu
Journal:  Eur Radiol       Date:  2019-02-22       Impact factor: 5.315

Review 5.  The Transjugular Intrahepatic Portosystemic Shunt: Technique and Instruments.

Authors:  Frederick S Keller; Khashayar Farsad; Josef Rösch
Journal:  Tech Vasc Interv Radiol       Date:  2016-01-28

6.  Survival benefit of TIPS versus serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis.

Authors:  R C Gaba; A Parvinian; L C Casadaban; P M Couture; S P Zivin; J Lakhoo; J Minocha; C E Ray; M G Knuttinen; J T Bui
Journal:  Clin Radiol       Date:  2015-03-07       Impact factor: 2.350

7.  Refractory Hepatic Encephalopathy After Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors and Outcomes with Revision.

Authors:  Michael W Rowley; Myunghan Choi; Steve Chen; Kevin Hirsch; Anil B Seetharam
Journal:  Cardiovasc Intervent Radiol       Date:  2018-06-05       Impact factor: 2.740

8.  Transjugular Intrahepatic Portosystemic Shunts in Patients with Cirrhosis with Refractory Ascites: Comparison of Clinical Outcomes by Using 8- and 10-mm PTFE-covered Stents.

Authors:  Roberto Miraglia; Luigi Maruzzelli; Fabio Tuzzolino; Ioannis Petridis; Mario D'Amico; Angelo Luca
Journal:  Radiology       Date:  2017-01-25       Impact factor: 11.105

9.  Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.

Authors:  Christophe Bureau; Dominique Thabut; Frédéric Oberti; Sébastien Dharancy; Nicolas Carbonell; Antoine Bouvier; Philippe Mathurin; Philippe Otal; Pauline Cabarrou; Jean Marie Péron; Jean Pierre Vinel
Journal:  Gastroenterology       Date:  2016-09-20       Impact factor: 22.682

10.  Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis.

Authors:  Laura Turco; Guadalupe Garcia-Tsao; Ilenia Magnani; Marcello Bianchini; Martina Costetti; Cristian Caporali; Stefano Colopi; Emilio Simonini; Nicola De Maria; Federico Banchelli; Rosario Rossi; Erica Villa; Filippo Schepis
Journal:  J Hepatol       Date:  2018-01-10       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.